Glenmark Pharmaceuticals Ltd 2019 SR
The report highlights Glenmark Pharmaceuticals' first GRI-based sustainability disclosure for the 2018-19 fiscal year. Key achievements include reaching over 1.4 million lives through CSR initiatives and maintaining 75% ISO 14001 certification across manufacturing facilities. The company focused on reducing its environmental footprint, achieving a 5.8% drop in specific energy consumption. Significant investments were made in R&D, totaling USD 113 million for its innovation-focused subsidiary. The report also details the company's climate strategy, water management efforts, and commitment to patient safety and product quality.
Company: Glenmark Pharmaceuticals Ltd
Sector: Manufacturing
Country: India
Year: 2019
Type: SR
Pages: 108
Glenmark Pharmaceuticals Ltd
The report highlights Glenmark Pharmaceuticals' first GRI-based sustainability disclosure for the 2018-19 fiscal year. Key achievements include reaching over 1.4 million lives through CSR initiatives and maintaining 75% ISO 14001 certification across manufacturing facilities. The company focused on reducing its environmental footprint, achieving a 5.8% drop in specific energy consumption. Significant investments were made in R&D, totaling USD 113 million for its innovation-focused subsidiary. The report also details the company's climate strategy, water management efforts, and commitment to patient safety and product quality.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2019
Reporting Period
Apr 1, 2018 - Mar 31, 2019
Fiscal Year
2019
Published
Jul 4, 2019
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees